Research ArticleArticle
Utility of Dose Frequency Adjustment in Tocilizumab Administration for Rheumatoid Arthritis
Shuntaro Saito, Yuko Kaneko, Keisuke Izumi and Tsutomu Takeuchi
The Journal of Rheumatology March 2017, jrheum.161047; DOI: https://doi.org/10.3899/jrheum.161047
Shuntaro Saito
From the Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. S. Saito, MD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; K. Izumi, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Rheumatologist, Professor, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. T. Takeuchi, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: tsutake@z5.keio.jp. Accepted for publication January 25, 2017.
Yuko Kaneko
From the Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. S. Saito, MD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; K. Izumi, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Rheumatologist, Professor, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. T. Takeuchi, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: tsutake@z5.keio.jp. Accepted for publication January 25, 2017.
Keisuke Izumi
From the Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. S. Saito, MD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; K. Izumi, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Rheumatologist, Professor, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. T. Takeuchi, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: tsutake@z5.keio.jp. Accepted for publication January 25, 2017.
Tsutomu Takeuchi
From the Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan. S. Saito, MD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; Y. Kaneko, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; K. Izumi, MD, PhD, Rheumatologist, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine; T. Takeuchi, MD, PhD, Rheumatologist, Professor, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine. Address correspondence to Dr. T. Takeuchi, Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. E-mail: tsutake@z5.keio.jp. Accepted for publication January 25, 2017.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Utility of Dose Frequency Adjustment in Tocilizumab Administration for Rheumatoid Arthritis
Shuntaro Saito, Yuko Kaneko, Keisuke Izumi, Tsutomu Takeuchi
The Journal of Rheumatology Mar 2017, jrheum.161047; DOI: 10.3899/jrheum.161047